Affinity-Matured B Cell Responses Neutralizing Type-I Interferons Underlie Severe Viral Infections
A recent study published in the journal Cell reveals that severe viral infections in humans are often driven by neutralizing autoantibodies against type-I interferons (IFNs). By integrating functional and structural biological approaches with advanced AI-based analysis, researchers determined that these harmful autoantibodies originate from pre-existing autoimmune conditions. The study highlights that prolonged affinity maturation within germinal centers is the primary mechanism driving the production of these antibodies. This process leads to the neutralization of type-I IFNs, which are critical components of the innate immune response against viruses. Consequently, individuals with these specific autoantibodies exhibit a compromised ability to fight off viral pathogens, resulting in more severe disease outcomes. This research provides significant insights into the immunological basis of severe viral susceptibility, linking it directly to specific B cell responses and autoimmune histories. The findings underscore the importance of understanding autoimmunity in the context of infectious disease severity and may inform future therapeutic strategies targeting these pathways.
Wire timeline
Affinity-Matured B Cell Responses Neutralizing Type-I Interferons Underlie Severe Viral Infections
A recent study published in the journal Cell reveals that severe viral infections in humans are often driven by neutralizing autoantibodies against type-I interferons (IFNs). By integrating functional and structural biological approaches with advanced AI-based analysis, researchers determined that these harmful autoantibodies originate from pre-existing autoimmune conditions. The study highlights that prolonged affinity maturation within germinal centers is the primary mechanism driving the production of these antibodies. This process leads to the neutralization of type-I IFNs, which are critical components of the innate immune response against viruses. Consequently, individuals with these specific autoantibodies exhibit a compromised ability to fight off viral pathogens, resulting in more severe disease outcomes. This research provides significant insights into the immunological basis of severe viral susceptibility, linking it directly to specific B cell responses and autoimmune histories. The findings underscore the importance of understanding autoimmunity in the context of infectious disease severity and may inform future therapeutic strategies targeting these pathways.
Cell